EQ · NASDAQ · Biotechnology

Equillium (EQ)

Develops EQ504, an investigational AhR modulator for ulcerative colitis and other inflammatory diseases.

$1.80
After hours+0.05 (+2.86%)
At close$1.75(−9.33%)